Despite slowing fiscal growth in China, government investments are ensuring that the country's pharmaceutical industry will continue to expand and attract private investment. Malaysia, too, is rapidly becoming a center of pharmaceutical and medical device manufacturing, with estimates that the medtech market there will hit $2.8 billion in four years. The assessments of both countries come from the BioSpectrum Asia Top 20 Survey.

Related Summaries